Archives shire

by in
Entry Author Date Location
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo 09/02/15 San Francisco
Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug 08/31/15 Boston
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher 08/31/15 New York
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More 08/07/15 Boston
Shire Snaps up New York’s Foresight Bio in $300M Pink Eye Deal 08/03/15 New York
Alexion Shells Out $8.4B for Synageva In Rare Disease Mega-Deal 05/06/15 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More 02/26/15 San Francisco
Shire Acquires Meritage Pharma in Deal Potentially Worth $245M 02/24/15 San Diego
Valeant to Acquire Specialty Pharma Salix in $14.5B Deal 02/22/15 Raleigh Durham
Report: Troubled Salix Emerges as Valeant’s Latest Takeover Target 02/03/15 Raleigh Durham
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
NPS Pharma’s Long Road Ends With a $5.2B Shire Buyout 01/11/15 New York
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
Canaan Closes $675M Fund, One Of Venture’s Ten Largest This Year 10/16/14 New York
Orphan Drug From Scioderm Aims to Treat Rare Skin Disease 10/07/14 Raleigh Durham
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
Standing on a Ledge Once Again, Amicus Holds Breath for Latest Study 08/11/14 New York
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
Oh Canada! Versant’s Strategic Shifts Lead to $300M Fund 07/08/14 San Francisco
Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs 06/18/14 Boston
Promedior Sees Hope in Small Myelofibrosis Study 05/30/14 Boston
West Coast Biotech Roundup: Lumena/Shire, Isis, Janssen Labs & More 05/16/14 San Diego
Page 1 of 4 next page »